Free Trial

UnitedHealth Group (UNH) Stock Price, News & Analysis

$580.32
+2.36 (+0.41%)
(As of 09/18/2024 ET)

About UnitedHealth Group Stock (NYSE:UNH)

Key Stats

Today's Range
$572.39
$584.23
50-Day Range
$504.28
$604.14
52-Week Range
$436.38
$607.94
Volume
2.99 million shs
Average Volume
4.02 million shs
Market Capitalization
$535.88 billion
P/E Ratio
35.47
Dividend Yield
1.45%
Price Target
$614.17
Consensus Rating
Buy

Company Overview

UnitedHealth Group Incorporated is a multinational, Minnetonka, Minnesota-based healthcare and insurance company. It is the result of 5 decades of mergers and acquisitions that began with the formation of Charter Med Inc in 1974. Charter Med Inc was a privately held medical services firm that was soon rebranded (1978) to United Healthcare Company. United Healthcare Company became the parent and holding company for the Physician’s Health Plan of Minnesota, an early HMO.

The company has had several key phases, including the late 1980s when it entered the pharmacy services industry; the mid-1990s when it made some major acquisitions to consolidate a large portion of the US HMO market, and the “modern” period in which it continues to pursue growth through acquisitions, expansion and deepening penetration. Among the more notable events are the inclusion of John Deere Healthcare and the restructuring of acquired assets into the Optum segment. Optum is UnitedHealth Group Incorporated’s technology-focused division and includes the staffed physical-care facilities located throughout the US.

Today, UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four segments providing healthcare and insurance products globally. The company’s four segments are UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. It is the world’s 7th largest company by revenue and the largest insurer by annual premiums. It is ranked 11th on the Forbes Fortune 500 list and had a market capitalization of nearly $500 billion at the end of 2022. Total revenue in 2022 topped $320 billion.

On a segment basis, The UnitedHealthcare segment is the largest and comprises roughly 80% of the net business. It offers consumer-oriented health benefit plans for businesses and consumers and preventative and well-being services for people over 50. It also manages Medicaid plans, family health plans and dental plans among other services.

The OptumHealth segment is a consumer-oriented platform to access a care providers and services network. The OptumInsight segment provides technology, services and outsourcing to hospitals, physicians and organizations that provide health insurance and/or health plans. The OptumRx segment serves the pharmacy industry including the retail market, home delivery and specialty services. Optum users can connect to physicians, schedule appointments, and even fill their prescriptions.

UnitedHealth Group has a long track record of dividend payments that dates back to 1990. The company also has a track record for increasing its dividend if not on a consistent annual basis. The company does not have a dividend reinvestment plan.

UnitedHealth Group is committed to sustainable operations for its consumers and the planet. To that end, the company has committed to efforts that help control healthcare costs, including telehealth and value-based arrangement with providers. Regarding the environment, the company has committed to net-zero emissions by 2035 which is well ahead of the global target. The company is also committed to health equity or the idea that healthcare opportunities (including employment) be fairly and equitably available to all.

UnitedHealth Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 99th Percentile

UnitedHealth Group scored higher than 99% of companies evaluated by MarketBeat, and ranked 12th out of 1,017 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    UnitedHealth Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 18 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    UnitedHealth Group has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about UnitedHealth Group's stock forecast and price target.
  • Earnings Growth

    Earnings for UnitedHealth Group are expected to grow by 12.71% in the coming year, from $27.69 to $31.21 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of UnitedHealth Group is 35.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.78.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of UnitedHealth Group is 35.47, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 138.61.

  • Price to Earnings Growth Ratio

    UnitedHealth Group has a PEG Ratio of 1.64. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    UnitedHealth Group has a P/B Ratio of 5.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about UnitedHealth Group's valuation and earnings.
  • Percentage of Shares Shorted

    0.85% of the float of UnitedHealth Group has been sold short.
  • Short Interest Ratio / Days to Cover

    UnitedHealth Group has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in UnitedHealth Group has recently decreased by 6.01%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    UnitedHealth Group pays a meaningful dividend of 1.43%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    UnitedHealth Group has been increasing its dividend for 15 years.

  • Dividend Coverage

    The dividend payout ratio of UnitedHealth Group is 51.34%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, UnitedHealth Group will have a dividend payout ratio of 26.91% next year. This indicates that UnitedHealth Group will be able to sustain or increase its dividend.

  • Read more about UnitedHealth Group's dividend.
  • Percentage of Shares Shorted

    0.85% of the float of UnitedHealth Group has been sold short.
  • Short Interest Ratio / Days to Cover

    UnitedHealth Group has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in UnitedHealth Group has recently decreased by 6.01%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    UnitedHealth Group has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 31 news articles for UnitedHealth Group this week, compared to 26 articles on an average week.
  • Search Interest

    102 people have searched for UNH on MarketBeat in the last 30 days. This is an increase of 5% compared to the previous 30 days.
  • MarketBeat Follows

    Only 27 people have added UnitedHealth Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -31% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, UnitedHealth Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,493,273.00 in company stock.

  • Percentage Held by Insiders

    Only 0.33% of the stock of UnitedHealth Group is held by insiders.

  • Percentage Held by Institutions

    87.86% of the stock of UnitedHealth Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about UnitedHealth Group's insider trading history.

UNH Stock News Headlines

Stock portfolio
Top Stress-Free Stock Picks to Secure Your Portfolio This Fall (UNH)
Beat the September slump and volatility surrounding the Fed's likely interest rate decision with a fast-growing B2B services firm and two blue chip stalwarts.
What is a blue chip company? Image of a guy pushing a blue chip in a shopping cart
What is a blue chip company? Overview and examples (UNH)
A blue chip is a publicly traded, well-established, financially sound company. Learn more about blue chips with MarketBeat.
Massive shakeup in defense contracting
There is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.
Seattle, WA USA - circa November 2022: Close up view of large bundles of toilet paper for sale inside a QFC grocery store.
3 Stocks to Own if You Are Bearish on The Market
Dividends, solid fundamentals, and a low beta are three qualities investors can use to insulate their portfolios during a bear market.
Microsoft logo and emblem. Microsoft is an international corporation that develops, supports and sells computer software and services worldwide.
3 Must-Own Stocks for Bullish Investors in Today's Market (UNH)
Three stocks stand out as the best names to keep in mind when remaining bullish in the market today, despite what the bears may say, analysts agree on these
UnitedHealth Group (NYSE:UNH) Upgraded to Buy by StockNews.com
UnitedHealth Group (NYSE:UNH) Given "Overweight" Rating at Cantor Fitzgerald
See More Headlines

UNH Stock Analysis - Frequently Asked Questions

UnitedHealth Group's stock was trading at $526.47 on January 1st, 2024. Since then, UNH shares have increased by 10.2% and is now trading at $580.32.
View the best growth stocks for 2024 here
.

UnitedHealth Group Incorporated (NYSE:UNH) announced its quarterly earnings results on Tuesday, July, 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.66 by $0.14. The firm's revenue was up 6.4% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of UnitedHealth Group: LHC Group, PreferredOne, divvyDOSE, Diplomat Pharmacy, PatientsLikeMe, Equian, Avella Specialty Pharmacy, and more.

UnitedHealth Group's top institutional shareholders include Legal & General Group Plc (0.90%), Bank of New York Mellon Corp (0.87%), Clearbridge Investments LLC (0.54%) and Dimensional Fund Advisors LP (0.41%). Insiders that own company stock include Richard T Burke, Stephen J Hemsley, John F Rex, Andrew Witty, Dirk C Mcmahon, Thomas E Roos, Frederick William Mcnabb III, Erin Mcsweeney and Paul R Garcia.
View institutional ownership trends
.

Shares of UNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that UnitedHealth Group investors own include NVIDIA (NVDA), Visa (V), Walt Disney (DIS), Johnson & Johnson (JNJ), Home Depot (HD), Alibaba Group (BABA) and JPMorgan Chase & Co. (JPM).

Company Calendar

Ex-Dividend for 6/25 Dividend
6/17/2024
Dividend Payable
6/25/2024
Last Earnings
7/16/2024
Ex-Dividend for 9/24 Dividend
9/16/2024
Today
9/18/2024
Dividend Payable
9/24/2024
Next Earnings (Confirmed)
10/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
CUSIP
91324P10
Employees
440,000
Year Founded
1977

Price Target and Rating

Average Stock Price Target
$614.17
High Stock Price Target
$680.00
Low Stock Price Target
$559.00
Potential Upside/Downside
+5.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
20 Analysts

Profitability

Net Income
$22.38 billion
Pretax Margin
5.25%

Debt

Sales & Book Value

Annual Sales
$371.62 billion
Cash Flow
$29.32 per share
Book Value
$102.08 per share

Miscellaneous

Free Float
917,348,000
Market Cap
$535.88 billion
Optionable
Optionable
Beta
0.58

Social Links

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 10, 2024. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in UnitedHealth Group:

  • UnitedHealth Group has shown consistent growth in revenue and earnings over the past few quarters, indicating financial stability and potential for future returns.
  • The company's strong presence in the healthcare industry, particularly through its UnitedHealthcare segment, provides a diversified revenue stream and resilience against market fluctuations.
  • Recent insider transactions show confidence in the company's performance, with insiders acquiring additional shares, signaling a positive outlook for UnitedHealth Group.
  • UnitedHealth Group's strategic acquisitions and partnerships, such as Optum Health and Optum Rx, have expanded its market reach and capabilities, positioning the company for long-term growth.
  • Considering the current stock price and the company's growth prospects, UnitedHealth Group may present a value investment opportunity for investors seeking stable returns in the healthcare sector.

UnitedHealth Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in UnitedHealth Group for these reasons:

  • Despite its strong performance, UnitedHealth Group faces regulatory risks in the healthcare sector, which could impact its operations and financial results.
  • The company's heavy reliance on institutional investors and hedge funds for ownership may lead to increased volatility in its stock price due to large-scale trading activities.
  • Market competition in the healthcare industry is intense, and UnitedHealth Group may face challenges in maintaining its market share and profitability against competitors.
  • Fluctuations in healthcare policies and reimbursement rates could affect UnitedHealth Group's revenue and margins, posing risks to its financial performance.
  • Investors should carefully monitor the company's debt levels and leverage ratios, as high debt burdens could constrain UnitedHealth Group's flexibility in pursuing growth opportunities and returning value to shareholders.

This page (NYSE:UNH) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners